Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Prevalence and determinants of human papillomavirus genital infection in men (2002)

  • Authors:
  • USP affiliated authors: ELUF NETO, JOSE - FM
  • USP Schools: FM
  • DOI: 10.1038/sj.bjc.6600194
  • Subjects: HÁBITOS; CARCINOMA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    DOI or search this record in
    Informações sobre o DOI: 10.1038/sj.bjc.6600194 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: hybrid
    • Licença: cc-by-nc-sa
    Informações sobre o Citescore
  • Título: British Journal of Cancer

    ISSN: 0007-0920

    Citescore - 2017: 5.75

    SJR - 2017: 2.89

    SNIP - 2017: 1.711


  • How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FRANCESCHI, S.; CASTELLSAGUÉ, X.; MASO, L. Dal; et al. Prevalence and determinants of human papillomavirus genital infection in men. British Journal of Cancer, Milan, v. 86, n. 5, p. 705-711, 2002. DOI: 10.1038/sj.bjc.6600194.
    • APA

      Franceschi, S., Castellsagué, X., Maso, L. D., Smith, J. S., Plummer, M., Ngelangel, C., et al. (2002). Prevalence and determinants of human papillomavirus genital infection in men. British Journal of Cancer, 86( 5), 705-711. doi:10.1038/sj.bjc.6600194
    • NLM

      Franceschi S, Castellsagué X, Maso LD, Smith JS, Plummer M, Ngelangel C, Chichareon S, Eluf Neto J, Shah KV, Snijders PJF, Meijer CJLM, Bosch FX, Muñoz N. Prevalence and determinants of human papillomavirus genital infection in men. British Journal of Cancer. 2002 ; 86( 5): 705-711.
    • Vancouver

      Franceschi S, Castellsagué X, Maso LD, Smith JS, Plummer M, Ngelangel C, Chichareon S, Eluf Neto J, Shah KV, Snijders PJF, Meijer CJLM, Bosch FX, Muñoz N. Prevalence and determinants of human papillomavirus genital infection in men. British Journal of Cancer. 2002 ; 86( 5): 705-711.

    Referências citadas na obra
    Baken LA, Koutsky LA, Kuypers J, Kosorok MR, Lee SK, Kiviat NB, Holmes KK (1995) Genital human papillomavirus infection among male and female sex partners: prevalence and type-specific concordance. J Infect Dis 171: 429–432
    Baldwin S, Wallace D, Abrahamsen M, Papenfuss M, Hallum J, Giuliano A (2001) Human papillomavirus infection among men attending an STD clinic. Proceedings of the 19th International Papillomavirus Conference, Florianopolis, 17 September 2001 Abstract No 0-85: 131
    Bosch FX, Cardis E (1990) Cancer incidence correlations: genital, urinary and some tobacco-related cancers. Int J Cancer 46: 178–184
    Bosch FX, Muñoz N, de Sanjosé S, Navarro C, Moreo P, Acunce N, Gonzalez LC, Tafur L, Gili M, Larrañaga I, Viladiu P, Daniel RW, Alonso de Ruiz P, Aristizabal N, Santamaria M, Guerrero E, Shah KV (1993) Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol Biomarkers Prev 2: 415–422
    Bosch FX, Castellsagué X, Muñoz N, de Sanjosé S, Ghaffari AM, Gonzàlez LC, Gili M, Izarzugaza I, Viladiu P, Navarro C, Vergara A, Ascunce N, Guerrero E, Shah KV (1996) Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain. J Natl Cancer Inst 88: 1060–1067
    Breslow NE, Day NE (1980) Statistical methods in cancer research. Volume I. In The analysis of case-control studies Vol I, IARC Sci Publ No 32: Lyon: International Agency for Research on Cancer
    Cates Jr W, Stone KM (1992) Family planning, sexually transmitted diseasese and contraceptive choice: a literature update – part I. Family Planning Perspective 24: 75–84
    Castellsagué X, Bosch FX, Muñoz N, Meijer CJLM, Shah KV, de Sanjosé S, Eluf-Neto J, Ngelangel C, Chichareon S, Smith JS, Herrero R, Franceschi S for the IARC Multicentric Cervical Cancer Study Group. (2002) Male circumcision penile human papillomavirus infection cervical cancer. New Engl J Med (In press)
    Castellsagué X, Ghaffari A, Daniel RW, Bosch FX, Muñoz N, Shah KV (1997) Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: a study in Spain and Colombia. J Infect Dis 176: 353–361
    Chichareon S, Herrero R, Muñoz N, Bosch FX, Jacobs MV, Deacon J, Santamaria M, Chongsuvivatwong V, Meijer CJLM, Walboomers JMM (1998) Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 90: 50–57
    de Roda Husman A-M, Walboomers JMM, van den Brule AJC, Meijer CJLM, Snijders PJF (1995) The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 75: 1057–1062
    Dürst M, Gissmann Husman, Ikenberg H, zur Hausen H (1983) A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80: 3812–3815
    Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJ, Walboomers JM (1994) Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 69: 114–119
    Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, Schiffman M (2000a) Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 92: 464–474
    Herrero R, Muñoz N, Lazcano E, Posso H, Sukvirach S, de Sanjosé S, Meijer CJLM, Coursaget P, Walboomers JMM (2000b) HPV international prevalence surveys in general populations. Proceedings of the 18th International Papillomavirus Conference, Barcelona, 23–28 July 2001: Abstract No 54. p 126
    Hippeläinen M, Syrjänen S, Hippeläinen M, Koskela H, Pulkkinen J, Saarikoski S, Syrjänen K (1993a) Prevalence and risk factors of genital human papillomavirus (HPV) infections in health males: a study on Finnish conscripts. Sex Trans Dis 20: 321–328
    Hippeläinen MI, Hippeläinen M, Saarikoski S, Syrjänen K (1993b) Clinical course and prognostic factors of human papillomavirus infections in men. Sex Trans Dis 21: 272–279
    Hippeläinen MI, Yliskoski M, Syrjänen S, Saastamoinen J, Hippeläinen M, Saarikoski S, Syrjänen K (1993c) Low concordance of genital human papillomavirus (HPV) lesions and viral types in HPV-infected women and their male sexual partners. Sex Trans Dis 21: 76–82
    Jacobs MV, de Roda Husman AM, van den Brule AJC, Snijders PJF, Meijer CJLM, Walboomers JMM (1995) Group specific differentiation between high- and low-risk human papillomavirus genotypes by general primers-mediated polymerase chain reaction and two cocktails of oligonucleotide-probes. J Clin Microbiol 33: 901–905
    Kjaer SK, Munk C, Winther JF, Meijer CJL, van den Brule AJC (2001) Incidence and persistence of HPV infection in young Danish men. A prospective follow-up study. Proceedings of the 19th International Papillomavirus Conference, Florianopolis, 1–7 September 2001. Abstract No O-88: 135
    Kyo S, Inoue M, Koyama M, Fujita M, Tanizawa O, Hakura A (1994) Detection of high-risk human papillomavirus in the cervix and semen of sex partners. J Infect Dis 170: 682–685
    Lazcano-Ponce E, Herrero R, Muñoz N, Hernandez-Avila M, Sameròn J, Leyva A, Meijer CJLM, Walboomers JMM (2001) High prevalence of human papillomavirus infection in Mexican males: comparative study of penile-urethral swabs and urine samples. Sex Trans Dis 28: 277–280
    Manos MM, Wright DK, Lewis AJ, Broker TR, Wolinsky SM (1989) The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. In Molecular diagnostics of human cancer Furth M, Greaves M (eds) pp. 209–214, Cold Spring Harbor, NY: Cold Spring Harbor Press
    Muñoz N, Bosch FX, de Sanjosé S, Tafur L, Izarzugaza I, Gili M, Viladiu P, Navarro C, Martos C, Ascunce N, Gonzalez LC, Kaldor JM, Guerrero E, Lörincz A, Santamaria M, Alonso de Ruiz P, Aristizabal N, Shah K (1992) The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 52: 743–749
    Muñoz N, Castellsagué X, Bosch FX, Tafur L, de Sanjosé S, Aristizabal N, Ghaffari AM, Shah KV (1996) Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease. J Natl Cancer Inst 88: 1068–1075
    Ngelangel C, Muñoz N, Bosch FX, Limson GM, Festin MR, Deacon J, Jacobs M, Santamaria M, Meijer CJLM, Walboomers JMM (1998) Causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 90: 43–49
    Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (1997) Cancer incidence in five continents. Vol. VII. IARC Sci Publ No 143: Lyon: International Agency for Research on Cancer
    Skegg DC, Corwin PA, Paul C, Doll R (1982) Importance of the male factor in cancer of the cervix. Lancet 2: 581–583
    Smith PG, Kinlen LJ, White GC, Adelstein AM, Fox AJ (1980) Mortality of wives of men dying with cancer of the penis. Br J Cancer 41: 422–428
    Strand A, Rylander E, Wilander E, Zehbe I (1995) HPV infection in male partners of women with squamous intraepithelial neoplasia and/or high-risk HPV. Acta Derm Venereol 75: Suppl Stokh 312–316
    Syrjänen K, Vayrynen M, Castren O, Yliskoski M, Mantyjarvi R, Pyrhonen S, Saarikoski S (1984) Sexual behavior of women with human papillomavirus (HPV) lesions of the uterine cervix. Br J Venereal Dis 60: 243–248
    van den Brule AJC, Meijerj CJLM, Bakels V, Kenemans P, Walboomers JMM (1990) Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J Clin Microbiol 28: 2739–2743
    Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Muñoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12–19
    Woodman CBJ, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason TP, Young LS (2001) Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357: 1831–1836